Retatrutide
Triple agonist peptide targeting GLP-1, GIP, and glucagon receptors. A next-generation compound for metabolic research applications.
Subscribe & Save
Recurring orders launching soon
Calculate your dose
Free reconstitution calculator, preset for Retatrutide.
About Retatrutide
Triple agonist peptide targeting GLP-1, GIP, and glucagon receptors. A next-generation compound for metabolic research applications.
Disclaimer: This product is sold for research purposes only. It is not intended for human consumption, diagnosis, treatment, or prevention of any disease. Always consult with a qualified professional.
The Weight Loss Protocol
You may also like
Tirzepatide
Dual GIP and GLP-1 receptor agonist peptide. Widely researched for its role in metabolic regulation and body composition studies.
CJC-1295 (no DAC)
Modified growth hormone releasing hormone analogue without drug affinity complex. Researched for pulsatile GH release patterns.
Ipamorelin
Selective growth hormone secretagogue peptide. Studied for targeted GH release without significant impact on cortisol or prolactin levels.